Skip to main
OPCH
OPCH logo

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 63%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc. has demonstrated strong financial performance, with gross profit reaching $269.0 million, representing an 8% year-over-year growth and exceeding expectations. The company reported a significant increase in gross margin dollar generation of 6.3% for the quarter, indicative of effective operational efficiencies. Additionally, the chronic therapy business has shown robust growth exceeding 10%, while the company has raised its revenue guidance for 2025, now estimating revenues between $5.5 billion and $5.65 billion, a 12% increase compared to the previous year.

Bears say

Option Care Health Inc. faces significant financial challenges, primarily driven by the potential loss of its largest customer, which accounted for 14% of the company's 2023 revenue, posing a substantial risk to revenue and profitability. Additionally, management has indicated a gross profit headwind of over $20 million related to Stelara, with an anticipated annual impact of $65-70 million, further complicating the company's financial outlook. Moreover, the expansion of gross margins is constrained due to the faster growth of lower-margin chronic therapies compared to higher-margin acute therapies, which could hinder future EBITDA margin improvement.

OPCH has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 63% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 8 analysts, OPCH has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.